References
- Warren JB. Vascular control of inflammatory oedema. Clin Sci 1993;84:581–4.
- Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clin Sci 1992;82:471–88.
- Persson CGA, Gustafsson B, Erjefält JS, Sundler F. Mucosal exudation of plasma is a noninjurious intestinal defence mechanism. Allergy 1993;48:581–6.
- Gustafsson B, Persson CGA. Allergen-induced mucosal exuadation of plasma into rat ileum and its inhibition by budesonide. Scand J Gastroenterol 1992;27:587–93.
- McHugh KJ, Svensjö E, Persson CGA. Exuadative and absorptive permeability in different phases of an experimental colitis condition. Scand J Gastroenterol 1996;31:900–5.
- Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1988;94:557–72.
- McKay DM, Brattsand R, Wieslander E, Fung M, Croitoru K, Perdue MH. Budesonide inhibits T-cell initiated epithelial pathophysiology in an in vitro model of inflammation. J Pharm Exp Ther 1996;277:403–10.
- Ekström GM. Oxzolone-induced colitis in rats: effects of budesonide, cyclosporin A, and 5-aminosalicylic acid. Scand J Gastroenterol 1998;33:174–9.
- Wagner HN Jr, Rhodes BA, Sasaki Y, Ryan JP. Studies of the circulation with labelled microspheres. Invest Radiol 1969; 4:374–386.
- Hillerdal M. Cochlear blood flow in the rat. A methodological evaluation of the microsphere method. Hearing Res 1984;27:27–35.
- Hillerdal M, Sperber GO, Bill A. The microsphere method for measuring low blood flows: theory and computer simulations applied to findings in the rat cochlea. Acta Physiol Scand 1987;130:229–35.
- Karbach U, Ewe K, Bodenstein H. Alpha1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn’s disease. Gut 1983;24: 718–23.
- Meyers S, Wolke A, Field SP, Feuer EJ, Johnson JW, Janowitz HD. Fecal α1-antitrypsin measurement: an indicator of Crohn’s disease activity. Gastroenterology 1985;89:13–8.
- Hultén L, Lindhagen J, Lundgren O, Fasth S, Åhrén C. Regional intestinal blood flow in ulcerative colitis and Crohn’s disease. Gastroenterology 1977;72:388–96.
- Tateishi S, Arima S, Futami K. Assessment of blood flow in the small intestine by laser Doppler flowmetry: comparison of healthy small intestine and small intestine in Crohn’s disease. J Gastroenterol 1997;32:457–63.
- Pantzar N, Ekström GM, Wang Q, Weström BR. Mechanisms of increased intestinal (51Cr)EDTA absorption during experimental colitis in the rat. Dig Dis Sci 1994;39:2327–33.
- Brown JA, Zipser RD. Prostaglandin regulation of colonic blood flow in rabbit colitis. Gastroenterology 1987;92:54–9.
- Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724–7.
- Andersen P, Milioni K, Maibach H. The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laserDoppler flowmetric study. Br J Dermatol 1993;128:660–5.
- Kjeldstrup Kristensen J, Wadskov S, Henriksen O. Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissue. Acta Derm Venereol (Stockh) 1978;58: 145–8.
- Tsurufuji S, Sugio K, Takemasa F. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature 1979;280:408–10.
- Björk J, Goldschmidt T, Smedegård G, Arfors K-E. Methyl-prednisolone acts at the endothelial cell level reducing inflammatory responses. Acta Physiol Scand 1985;123:221–3.
- Svensjö E, Roempke K. Time-dependent inhibition of bradykinin- and histamine-induced microvascular permeability increase by local glucocorticoid treatment. Prog Resp Res 1985; 19:173–80.
- Oyanagui Y, Suzuki S. Vasoregulin, a glucocorticoid-inducible vascular premeability inhibitory protein. Agents Actions 1985; 17:270–7.